Low Carbon Acrylic Unit Could Be A Game Changer For Arkema (ENXTPA:AKE)

• Arkema recently brought online a new acrylic acid purification unit at its Carling site in France, improving energy efficiency by 25% and cutting the site’s carbon intensity by 20% as part of a roughly €150 million decarbonization program supported by French and EU funding.
• By pairing low carbon acrylic capacity at Carling with a €10 million expansion of its Global Battery Center of Excellence, Arkema is tying capital spending directly to higher value applications such as advanced coatings, adhesives and battery materials rather than basic commodity output.
• This development may influence how investors view Arkema’s new low energy acrylic purification unit within the company’s broader investment narrative and outlook.

Spot 174 high quality undervalued stocks where companies, such as Arkema pivoting into low carbon materials and battery technologies, are positioning their capital toward higher margin, future-facing applications.

Arkema Investment Narrative Recap

For Arkema, the core belief is that specialty materials, decarbonization and battery related demand can gradually outweigh weak cyclical markets like construction and automotive. The new low energy acrylic unit fits that story because it targets cost efficiency and lower carbon intensity rather than sheer volume. In the near term, the key swing factor still looks like basic demand stabilization in Europe and North America.

The biggest immediate risk remains subdued volumes and pricing pressure in acrylics and other intermediates, amplified by competition from Asian producers and prior overcapacity. Higher leverage and financing costs add pressure if cash generation softens. The Carling upgrade helps on energy use and cost per ton but does not change those macro and capacity risks on its own.

Among the recent updates, the €10 million expansion of Arkema’s Global Battery Center of Excellence in France is closest to this acrylic investment. Both point to a push toward higher value formulations in batteries, coatings and adhesives that rely on acrylics and other specialty materials, rather than commoditized intermediates.

For catalysts, that battery R&D build out matters because it can support qualification of Arkema materials with cell makers under real production conditions. Execution risk is clear, as spending ramps while earnings have recently been pressured by low margins and one off items. If customer adoption of these advanced materials is slower than expected, payback on both the Carling and battery center projects could take longer to show up in reported results.

Arkema's current revenue framework assumes 3.2% yearly growth, with sales projected to reach €9.7 billion and earnings €428.8 million by 2029, compared with current earnings of €17.0 million. This implies an earnings increase of about €412 million over that period.

Uncover how Arkema's fair value indicates a 16% potential upside to its current price that could narrow quickly if sentiment toward Arkema shifts.

Exploring Other Perspectives

One alternate view focuses less on Arkema’s decarbonization wins and more on the drag from Primary Materials. The lowest analysts were only pencilling in revenue of about €9.5b and earnings of €345.7 million by 2029 before this news. That is a much more cautious story. Use this upgrade to recheck which narrative you find more convincing.

Explore 4 other Arkema fair value estimates, including one that suggests it could be worth just €62.79.

Form Your Own Verdict

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

• A great starting point for your Arkema research is our analysis highlighting 2 key rewards and 3 important warning signs that could impact your investment decision.
• See our latest analysis for Arkema. The report includes a comprehensive fundamental analysis summarized in a single visual, the Snowflake, making it easy to evaluate Arkema's overall financial health at a glance.

Looking for more Arkema style investment ideas?

If the Arkema story has you rethinking where capital is flowing, use the Simply Wall St Screener to spot other businesses that line up with the kind of risk and reward profile you want in your portfolio.

• If you want strong quality at a discount, start with a curated pool of companies screened as 174 high quality undervalued stocks that may offer more resilient fundamentals at current prices.
• If capital preservation and steadier rides matter most, focus on a 222 resilient stocks with low risk scores that filters for businesses with more stable financial and risk profiles.
• If you prefer sturdier balance sheets behind each ticker, work through a list of solid balance sheet and fundamentals (204 results) to find businesses with stronger funding structures backing their operations.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com